1. What’s happening
Amazon is expanding its Health AI agent and access to GLP-1 treatments, embedding both within its broader, app-based healthcare experience.
- In March, Amazon expanded its Health AI agent beyond the One Medical app, embedding it directly into Amazon.com and its mobile app, marking the first time the tool has been available at scale to general consumers.
- Amazon Pharmacy said Thursday that it will dispense the Ozempic pill for type 2 diabetes at its One Medical kiosks, which Amazon Pharmacy launched at select One Medical locations in December, and enable same-day delivery for $149 monthly, eliminating a separate pharmacy trip.
- Amazon in April launched a One Medical GLP-1 management program offering oral GLP-1s for weight-loss like Eli Lilly’s Foundayo and Novo’s Wegovy.
- The retail giant has also expanded access beyond One Medical. Anyone, regardless of being a One Medical member, can start the GLP-1 program, use the prescription kiosks, and schedule an appointment, and non-members with an existing prescription can access cash-pay, on-demand, 24/7 telehealth prescription renewals.
2. What’s the big deal
Amazon is positioning itself as both the front door and fulfillment engine for healthcare, giving patients yet another reason to stay within the Amazon healthcare ecosystem.
- Health AI — now sitting inside the world’s largest online marketplace — beckons patients to start their health journeys in the same place they shop.
- With roughly 180 million Prime members in the U.S., Amazon already has a built-in audience at massive scale.
- Beyond answering questions, Health AI can schedule appointments, read lab results, and manage prescriptions.
- Primary care (One Medical), pharmacy, retail distribution, and home delivery complete the consumer experience. Last year, Amazon said it was spending $4 billion on expanding its medication delivery network to small towns and rural areas.
- Much like an in-person pharmacy, patients can view upfront costs — estimated copays, available discounts, and out-of-pocket costs — right in the Amazon app.
3. What’s at stake
An entirely different healthcare experience.
- Amazon is introducing a consumer-centric alternative: on-demand, digitally coordinated, and integrated end to end.
- The recent moves connect discovery (Health AI), care (One Medical), and fulfillment (pharmacy, kiosks, delivery) into a single, more unified consumer experience.
- The strategy mirrors Amazon’s broader retail playbook: reduce friction and keep the entire journey within one platform.
- A shift toward control of the healthcare journey to platform ecosystems could redefine who owns patient relationships.
4. What’s it mean for commercial execs
If patients increasingly engage with healthcare through platforms like Amazon, commercialization strategies may need to move upstream in the patient journey, observes Rishi Manchanda, associate partner at Beghou.
- “Patients may form awareness, questions, and provider preferences inside platforms like Amazon before they ever speak with an HCP,” Manchanda explains.
- In turn, patient identification and targeting may shift away from geography and HCP affiliation, as digital platforms decouple care from local provider networks.
- Moreover, the Health AI app could become a new commercialization touchpoint, sitting earlier in the patient journey than physicians or payers, influencing things like therapy awareness and education, treatment pathway navigation, and provider selection.
- Then again, home delivery was also found to be a boon for adherence, increasing medication refills and lowering out-of-pocket costs, according to Amazon Pharmacy findings published in JAMA Network last year.
5. What’s next
Overall, this suggests the need to shift from influencing decisions at the point of care to engaging patients earlier, in the platforms where journeys begin.
- Manchanda counsels brands to optimize content for AI-driven search (i.e., through generative engine optimization, or GEO) and platform discovery: “Brand education needs to be compliant, clear, and findable in AI/search-led healthcare experiences, not just on brand websites or traditional media,” he stresses.
- This also prompts a rethink of patient services and measurement: “Co-pay, onboarding, refills, adherence, and education may need to connect into platform-based journeys,” he adds, “with measurement expanding beyond media clicks to digital starts, refills, adherence, and platform-driven behavior.”
- Amazon, one of many new entrants making major healthcare announcements this year, will likely have the biggest impact in terms of displacing and/or bypassing traditional channels, such as health systems, payers, pharmacy benefit managers, and pharmacies.
- That means healthcare incumbents will need to “rethink how, where, and when they show up for patients,” as one analyst noted, in a healthcare journey that is increasingly shaped outside the traditional system.